ABAC Therapeutics Announces €16 Million Series A to develop therapeutic solutions to fight antibiotic-resistant bacteria BARCELONA, Spain – February 15th, 2018 — ABAC Therapeutics (ABAC), a leader in pathogen-specific antibiotics, announced today the closing of a €16 million Series A round. The financing was led by Pontifax with participation from […]
Infectious Diseases
1 post